Search research articles
Contact Us
Filters
Showing results (11-20 of 159) with videos related to
Page
of 16
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 15, 2000
Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances
D Khayat, D Coeffic
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 28, 1998
[The role of new drugs in the treatment of locally advanced urothelial tumors of the bladder]
E C Antoine, D Khayat
Seminars in Oncology
|
October 26, 2000
Targeting progress: the development of growth factor receptor-directed therapy
G N Hortobagyi, D Khayat
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
European School of Oncology European consensus on the use of granulocyte colony-stimulating factor: the example of breast cancer
E C Antoine, D Khayat
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
Dose intensification and breast cancer: current results and future perspectives
E C Antoine, D Khayat
La Nouvelle Presse Medicale
|
April 11, 1981
[Late mediastinal recurrences in 2 patients with non-Hodgkin's lymphosarcoma]
C Jacquillat, M Weil, D Khayat
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
[Neo-adjuvant chemotherapy: a correct concept, an ambiguous term and multiple applications]
C Jacquillat, M Weil, D Khayat
Melanoma Research
|
November 30, 2000
Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma
R Mouawad, D Khayat, C Soubrane
Presse Medicale (Paris, France : 1983)
|
March 29, 1984
[Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)]
C Jacquillat, D Khayat, J Maral
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer
L Saltz, Y Shimada, D Khayat
Page
of 16
Search research articles
Search
Showing results (11-20 of 159) with videos related to
Sort By:
Page
of 16
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 15, 2000
Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances
D Khayat, D Coeffic
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 28, 1998
[The role of new drugs in the treatment of locally advanced urothelial tumors of the bladder]
E C Antoine, D Khayat
Seminars in Oncology
|
October 26, 2000
Targeting progress: the development of growth factor receptor-directed therapy
G N Hortobagyi, D Khayat
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
European School of Oncology European consensus on the use of granulocyte colony-stimulating factor: the example of breast cancer
E C Antoine, D Khayat
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
Dose intensification and breast cancer: current results and future perspectives
E C Antoine, D Khayat
La Nouvelle Presse Medicale
|
April 11, 1981
[Late mediastinal recurrences in 2 patients with non-Hodgkin's lymphosarcoma]
C Jacquillat, M Weil, D Khayat
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
[Neo-adjuvant chemotherapy: a correct concept, an ambiguous term and multiple applications]
C Jacquillat, M Weil, D Khayat
Melanoma Research
|
November 30, 2000
Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma
R Mouawad, D Khayat, C Soubrane
Presse Medicale (Paris, France : 1983)
|
March 29, 1984
[Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)]
C Jacquillat, D Khayat, J Maral
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer
L Saltz, Y Shimada, D Khayat
Page
of 16